These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37968979)

  • 1. Low-dose buprenorphine initiation in the era of fentanyl and fentanyl analogs: A case series of outpatient inductions.
    Ahmed S; Faruqui Z; Poddar K; Bhivandkar S; Suzuki J
    J Opioid Manag; 2023; 19(5):455-460. PubMed ID: 37968979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone Induction for a Patient With Precipitated Withdrawal in the Emergency Department: A Case Report.
    Church B; Clark R; Mohn W; Potee R; Friedmann P; Soares WE
    J Addict Med; 2023 May-Jun 01; 17(3):367-370. PubMed ID: 37267195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community based buprenorphine micro-induction in the context of methadone maintenance treatment and fentanyl - Case report.
    Kaliamurthy S; Jegede O; Hermes G
    J Addict Dis; 2023; 41(2):175-180. PubMed ID: 35377273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Uses of Methadone Under the "72-Hour Rule" to Facilitate Transitions of Care and Low-Dose Buprenorphine Induction in an Outpatient Bridge Clinic.
    Shahlapour M; Singh S; Christine PJ; Laks J; Evans J; Farrell NM; Khan GK; Taylor JL; Rozansky H
    J Addict Med; 2024 May-Jun 01; 18(3):345-347. PubMed ID: 38329815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid microinduction of sublingual buprenorphine from methadone in an outpatient setting: "A case series".
    Singh G; Sri Konakanchi J; Betsch B; Thapa A; Sethi R
    J Opioid Manag; 2021; 17(7):167-170. PubMed ID: 34520038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of opioid withdrawal and initiation of medications for opioid use disorder in the hospital setting.
    Carswell N; Angermaier G; Castaneda C; Delgado F
    Hosp Pract (1995); 2022 Oct; 50(4):251-258. PubMed ID: 35837678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caring for Hospitalized Adults With Opioid Use Disorder in the Era of Fentanyl: A Review.
    Englander H; Thakrar AP; Bagley SM; Rolley T; Dong K; Hyshka E
    JAMA Intern Med; 2024 Jun; 184(6):691-701. PubMed ID: 38683591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating opioid use disorder with rapid micro induction technique of sublingual buprenorphine/naloxone in an outpatient setting-a case report.
    Martell JP; Konakanchi JS; Sethi R
    J Addict Dis; 2022; 40(3):439-443. PubMed ID: 35072589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medications for management of opioid use disorder.
    Koehl JL; Zimmerman DE; Bridgeman PJ
    Am J Health Syst Pharm; 2019 Jul; 76(15):1097-1103. PubMed ID: 31361869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withdrawal during outpatient low dose buprenorphine initiation in people who use fentanyl: a retrospective cohort study.
    Jones BLH; Geier M; Neuhaus J; Coffin PO; Snyder HR; Soran CS; Knight KR; Suen LW
    Harm Reduct J; 2024 Apr; 21(1):80. PubMed ID: 38594721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid Low-dose Buprenorphine Initiation for Hospitalized Patients With Opioid Use Disorder.
    Sokolski E; Skogrand E; Goff A; Englander H
    J Addict Med; 2023 Jul-Aug 01; 17(4):e278-e280. PubMed ID: 37579112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METHADONE INITIATION IN THE EMERGENCY DEPARTMENT FOR OPIOID USE DISORDER: A CASE SERIES.
    Huo S; Heil J; Salzman MS; Carroll G; Haroz R
    J Emerg Med; 2023 Mar; 64(3):391-396. PubMed ID: 37019500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-Dose Initiation of Buprenorphine: A Narrative Review.
    Edinoff AN; Fahmy OH; Spillers NJ; Zaheri AR; Jackson ED; De Witt AJ; Wenger DM; Cornett EM; Skidmore KL; Kaye AM; Kaye AD
    Curr Pain Headache Rep; 2023 Jul; 27(7):175-181. PubMed ID: 37083890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose Buprenorphine Initiation in Hospitalized Adults With Opioid Use Disorder: A Retrospective Cohort Analysis.
    Button D; Hartley J; Robbins J; Levander XA; Smith NJ; Englander H
    J Addict Med; 2022 Mar-Apr 01; 16(2):e105-e111. PubMed ID: 34001775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone to buprenorphine/naloxone induction without withdrawal utilizing transdermal fentanyl bridge in an inpatient setting-Azar method.
    Azar P; Nikoo M; Miles I
    Am J Addict; 2018 Dec; 27(8):601-604. PubMed ID: 30387894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Dose Buprenorphine Induction With Full Agonist Overlap in Hospitalized Patients With Opioid Use Disorder: A Retrospective Cohort Study.
    Bhatraju EP; Klein JW; Hall AN; Chen DR; Iles-Shih M; Tsui JI; Merrill JO
    J Addict Med; 2022 Jul-Aug 01; 16(4):461-465. PubMed ID: 34954743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy of Opioid Use Disorder-Update and Current Challenges.
    Racha S; Buresh M; Fingerhood M
    Psychiatr Clin North Am; 2022 Sep; 45(3):335-346. PubMed ID: 36055727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an intravenous low-dose buprenorphine initiation protocol.
    Jablonski LA; Bodnar AR; Stewart RW
    Drug Alcohol Depend; 2022 Aug; 237():109541. PubMed ID: 35753281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful Buprenorphine/Naloxone Low-dose Induction in Pregnancy: A Case Report.
    Coish R; Hardial J
    J Addict Med; 2023 Jan-Feb 01; 17(1):114-116. PubMed ID: 35916416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micro-dosing Intravenous Buprenorphine to Rapidly Transition From Full Opioid Agonists.
    Thakrar AP; Jablonski L; Ratner J; Rastegar DA
    J Addict Med; 2022 Jan-Feb 01; 16(1):122-124. PubMed ID: 33758112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.